Drug Delivery System Based On Minoxidil Nanoparticles Promotes Hair Growth In C57BL/6 Mice

References

• Ellis JA, Sinclair RD. Male pattern baldness: current treatments, future prospects. Drug Discov Today. 2008;13:791–797. doi:10.1016/j.drudis.2008.05.01018617016
   PubMed Web of Science ®Google Scholar
• Khan MZU, Khan SA, Ubaid M, Shah A, Kousar R, Murtaza G. Finasteride topical delivery systems for androgenetic alopecia. Curr Drug Deliv. 2018;15:1100–1111. doi:10.2174/156720181566618012411290529366416
   PubMed Web of Science ®Google Scholar
• Mura S, Manconi M, Sinico C, Valenti D, Fadda AM. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of monoxidil. Int J Pharm. 2009;380:72–79. doi:10.1016/j.ijpharm.2009.06.04019589377
   PubMed Web of Science ®Google Scholar
• Aronson JK. Minoxidil In: Aronson JK, editor. Meyler’s Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. Amsterdam: Elsevier; 2006:2354–2356.
   Google Scholar
• Pavithran K. Erythema multiforme following topical minoxidil. Indian J Dermatol Venerol Leprol. 1993;59:313–314.
   Google Scholar
• Wagner L, Kenreigh C. Minoxidil In: Enna SJ, David BB, editors. xPharm: The Comprehensive Pharmacology Reference. Amsterdam: Elsevier; 2007:1–5.
   Google Scholar
• Padois K, Cantiéni C, Bertholle V, Bardel C, Pirot F, Falson F. Solid lipid nanoparticles suspension versus commercial solutions for dermal delivery of minoxidil. Int J Pharm. 2011;416:300–304. doi:10.1016/j.ijpharm.2011.06.01421704140
   PubMed Web of Science ®Google Scholar
• Knorr F, Lademann J, Patzelt A, Sterry W, Blume-Peytavi U, Vogt A. Follicular transport route–research progress and future perspectives. Eur J Pharm Biopharm. 2009;71:173–180. doi:10.1016/j.ejpb.2008.11.00119041720
   PubMed Web of Science ®Google Scholar
• Lademann J, Richter H, Teichmann A, et al. Nanoparticles – an efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm. 2007;66:159–164. doi:10.1016/j.ejpb.2006.10.01917169540
   PubMed Web of Science ®Google Scholar
• Prow TW, Grice JE, Lin LL, et al. Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev. 2011;63:470–491. doi:10.1016/j.addr.2011.01.01221315122
   PubMed Web of Science ®Google Scholar
• Yoon G, Park JW, Yoon I-S. Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs): recent advances in drug delivery. J Pharm Investig. 2013;43:353–362. doi:10.1007/s40005-013-0087-y
   Google Scholar
• Aljuffali IA, Pan TL, Sung CT, Chang SH, Fang JY. Anti-PDGF receptor β antibody-conjugated squarticles loaded with minoxidil for alopecia treatment by targeting hair follicles and dermal papilla cells. Nanomedicine. 2015;11:1321–1330. doi:10.1016/j.nano.2015.04.00925933696
   PubMed Web of Science ®Google Scholar
• Gelfuso GM, Barros MA, Delgado-Charro MB, Guy RH, Lopez RF. Iontophoresis of minoxidil sulphate loaded microparticles, a strategy for follicular drug targeting? Colloids Surf B Biointerfaces. 2015;134:408–412. doi:10.1016/j.colsurfb.2015.07.03126222406
   PubMed Web of Science ®Google Scholar
• Gelfuso GM, Gratieri T, Simão PS, de Freitas LA, Lopez RF. Chitosan microparticles for sustaining the topical delivery of minoxidil sulphate. J Microencapsul. 2011;28:650–658. doi:10.3109/02652048.2011.60443521824068
   PubMed Web of Science ®Google Scholar
• Matos BN, Reis TA, Gratieri T, Gelfuso GM. Chitosan nanoparticles for targeting and sustaining minoxidil sulphate delivery to hair follicles. Int J Biol Macromol. 2015;75:225–229. doi:10.1016/j.ijbiomac.2015.01.03625647618
   PubMed Web of Science ®Google Scholar
• Nagai N, Ito Y, Okamoto N, Shimomura Y. A nanoparticle formulation reduces the corneal toxicity of indomethacin eye drops and enhances its corneal permeability. Toxicology. 2014;319:53–62. doi:10.1016/j.tox.2014.02.01224598350
   PubMed Web of Science ®Google Scholar
• Nagai N, Yoshioka C, Ito Y, Funakami Y, Nishikawa H, Kawabata A. Intravenous administration of cilostazol nanoparticles ameliorates acute ischemic stroke in a cerebral ischemia/reperfusion-induced injury model. Int J Mol Sci. 2015;16:29329–29344. doi:10.3390/ijms16122616626690139
   PubMedGoogle Scholar
• Nagai N, Ogata F, Otake H, Nakazawa Y, Kawasaki N. Design of a transdermal formulation containing raloxifene nanoparticles for osteoporosis treatment. Int J Nanomedicine. 2018;13:5215–5229. doi:10.2147/IJN.S17321630233182
   PubMed Web of Science ®Google Scholar
• Nagai N, Ogata F, Ishii M, et al. Involvement of endocytosis in the transdermal penetration mechanism of ketoprofen nanoparticles. Int J Mol Sci. 2018;19:pii:E2138. doi:10.3390/ijms19072138
   Web of Science ®Google Scholar
• Nagai N, Iwamae A, Tanimoto S, Yoshioka C, Ito Y. Pharmacokinetics and antiinflammatory effect of a novel gel system containing ketoprofen solid nanoparticles. Biol Pharm Bull. 2015;38:1918–1924. doi:10.1248/bpb.b15-0056726632183
   PubMed Web of Science ®Google Scholar
• Müller-Röver S, Handjiski B, van der Veen C, et al. A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol. 2001;117:3–15. doi:10.1046/j.0022-202x.2001.01377.x11442744
   PubMed Web of Science ®Google Scholar
• Slominski A, Paus R, Plonka P, et al. Melanogenesis during the anagen-catagen-telogen transformation of the murine hair cycle. J Investig Dermatol. 1994;102:862–869. doi:10.1111/1523-1747.ep123826068006449
   PubMed Web of Science ®Google Scholar
• Nagai N, Ogata F, Otake H, Nakazawa Y, Kawasaki N. Energy-dependent endocytosis is responsible for drug transcorneal penetration following the instillation of ophthalmic formulations containing indomethacin nanoparticles. Int J Nanomedicine. 2019;14:1213–1227. doi:10.2147/IJN.S19668130863055
   PubMed Web of Science ®Google Scholar
• Kim MJ, Lim C, Lee JY, Im KR, Yoon KS, Song JM. Visible-to-near IR quantum dot-based hypermulticolor high-content screening of herbal medicines for the efficacy monitoring of hair growth promotion and hair loss inhibition. J Biomol Screen. 2013;18:462–473. doi:10.1177/108705711246457423190736
   PubMedGoogle Scholar
• Park KS, Park DH. Comparison of Saccharina japonica-Undaria pinnatifida mixture and minoxidil on hair growth promoting effect in mice. Arch Plast Surg. 2016;43:498–505. doi:10.5999/aps.2016.43.6.49827896178
   PubMedGoogle Scholar
• Zhang Y, Chen S, Qu F, Su G, Zhao Y. In vivo and in vitro evaluation of hair growth potential of Cacumen Platycladi, and GC-MS analysis of the active constituents of volatile oil. J Ethnopharmacol. 2019;238:111835. doi:10.1016/j.jep.2019.11183530917929
   PubMedGoogle Scholar
• Angunsri N, Taura A, Nakagawa T, et al. Insulin-like growth factor 1 protects vestibular hair cells from aminoglycosides. Neuroreport. 2011;22:38–43. doi:10.1097/WNR.0b013e32834273e921127443
   PubMedGoogle Scholar
• Yano K, Brown LF, Detmar M. Control of hair growth and follicle size by VEGF-mediated angiogenesis. J Clin Invest. 2001;107:409–417. doi:10.1172/JCI1131711181640
   PubMed Web of Science ®Google Scholar